| Year |
Citation |
Score |
| 2023 |
Mori JO, Elhussin I, Brennen WN, Graham MK, Lotan TL, Yates CC, De Marzo AM, Denmeade SR, Yegnasubramanian S, Nelson WG, Denis GV, Platz EA, Meeker AK, Heaphy CM. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer. Nature Reviews. Urology. PMID 37907729 DOI: 10.1038/s41585-023-00827-x |
0.345 |
|
| 2023 |
Mori JO, Keegan J, Flynn RL, Heaphy CM. Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer. Journal of Clinical Pathology. PMID 37890990 DOI: 10.1136/jcp-2023-209005 |
0.402 |
|
| 2023 |
Ertunc O, Smearman E, Zheng Q, Hicks JL, Brosnan-Cashman JA, Jones T, Gomes-Alexandre C, Trabzonlu L, Meeker AK, De Marzo AM, Heaphy CM. Chromogenic detection of telomere lengths in situ aids the identification of precancerous lesions in the prostate. Biorxiv : the Preprint Server For Biology. PMID 37066381 DOI: 10.1101/2023.04.04.535575 |
0.316 |
|
| 2022 |
Jafari N, Chen A, Kolla M, Pompa IR, Qiu Y, Yu R, Llevenes P, Ennis CS, Mori J, Mahdaviani K, Halpin M, Gignac GA, Heaphy CM, Monti S, Denis GV. Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease. Advances in Cancer Biology - Metastasis. 6. PMID 36644690 DOI: 10.1016/j.adcanc.2022.100073 |
0.372 |
|
| 2022 |
Low JY, Ko M, Hanratty B, Patel RA, Bhamidipati A, Heaphy CM, Sayar E, Lee JK, Li S, De Marzo AM, Nelson WG, Gupta A, Yegnasubramanian S, Ha G, Epstein JI, et al. Genomic Characterization of Prostatic Basal Cell Carcinoma. The American Journal of Pathology. PMID 36309102 DOI: 10.1016/j.ajpath.2022.09.010 |
0.319 |
|
| 2022 |
Heaphy CM, Joshu CE, Barber JR, Davis C, Lu J, Zarinshenas R, Giovannucci E, Mucci LA, Stampfer MJ, Han M, De Marzo AM, Lotan TL, Platz EA, Meeker AK. The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy. The Journal of Pathology. Clinical Research. PMID 35836303 DOI: 10.1002/cjp2.288 |
0.368 |
|
| 2021 |
Shrestha E, Coulter JB, Guzman W, Ozbek B, Hess MM, Mummert L, Ernst SE, Maynard JP, Meeker AK, Heaphy CM, Haffner MC, De Marzo AM, Sfanos KS. Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34341114 DOI: 10.1073/pnas.2018976118 |
0.314 |
|
| 2020 |
Hempel Sullivan H, Maynard JP, Heaphy CM, Lu J, De Marzo AM, Lotan TL, Joshu CE, Sfanos KS. Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomes. The Journal of Pathology. PMID 33338262 DOI: 10.1002/path.5606 |
0.407 |
|
| 2020 |
Heaphy CM, Bi WL, Coy S, Davis C, Gallia GL, Santagata S, Rodriguez FJ. Telomere length alterations and ATRX/DAXX loss in pituitary adenomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 32203094 DOI: 10.1038/S41379-020-0523-2 |
0.336 |
|
| 2020 |
Hempel Sullivan H, Heaphy CM, Kulac I, Cuka N, Lu J, Barber JR, De Marzo AM, Lotan TL, Joshu CE, Sfanos KS. High Extra-tumoral Mast Cell Counts are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31932412 DOI: 10.1158/1055-9965.Epi-19-0962 |
0.334 |
|
| 2020 |
Heaphy CM, Joshu CE, Barber JR, Davis C, Zarinshenas R, De Marzo AM, Lotan TL, Sfanos KS, Meeker AK, Platz EA. Racial difference in prostate cancer cell telomere lengths in men with higher-grade prostate cancer: a clue to the racial disparity in prostate cancer outcomes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31915143 DOI: 10.1158/1055-9965.Epi-19-1462 |
0.333 |
|
| 2020 |
Agurs-Collins T, Barber J, Bienstock J, Green P, Heaphy C, Lu J, Meeker A, Rizzo A, Rohrmann S, Platz E. Abstract C027: Racial variation in umbilical cord blood vitamin D concentrations and telomere length: Implications for cancer risk Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-C027 |
0.3 |
|
| 2019 |
Graham MK, Kim J, Da J, Brosnan-Cashman JA, Rizzo A, Baena Del Valle JA, Chia L, Rubenstein M, Davis C, Zheng Q, Cope L, Considine M, Haffner MC, De Marzo AM, Meeker AK, ... Heaphy CM, et al. Functional loss of ATRX and TERC activates Alternative Lengthening of Telomeres (ALT) in LAPC4 prostate cancer cells. Molecular Cancer Research : McR. PMID 31611308 DOI: 10.1158/1541-7786.Mcr-19-0654 |
0.389 |
|
| 2019 |
Zarif JC, Baena-Del Valle JA, Hicks JL, Heaphy CM, Vidal I, Luo J, Lotan TL, Hooper JE, Isaacs WB, Pienta KJ, De Marzo AM. Mannose Receptor-positive Macrophage Infiltration Correlates with Prostate Cancer Onset and Metastatic Castration-resistant Disease. European Urology Oncology. 2: 429-436. PMID 31277779 DOI: 10.1016/J.Euo.2018.09.014 |
0.438 |
|
| 2019 |
Zarif JC, Valle JAB, Hicks JL, Heaphy CM, Vidal I, Luo J, Lotan TL, Hooper JE, Isaacs WB, Pienta KJ, Marzo AMD. Abstract 4582: Mannose receptor positive macrophage infiltrate correlates with prostate cancer onset and metastatic castration-resistant disease Cancer Research. 79: 4582-4582. DOI: 10.1158/1538-7445.Am2019-4582 |
0.443 |
|
| 2018 |
Marrone MT, Joshu CE, Peskoe SB, De Marzo AM, Heaphy CM, Lupold SE, Meeker AK, Platz EA. Adding the Team into T1 Translational Research: A Case Study of Multidisciplinary Team Science in the Evaluation of Biomarkers of Prostate Cancer Risk and Prognosis. Clinical Chemistry. PMID 30518666 DOI: 10.1373/Clinchem.2018.293365 |
0.389 |
|
| 2018 |
Brosnan-Cashman JA, Yuan M, Graham MK, Rizzo AJ, Myers KM, Davis C, Zhang R, Esopi DM, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner. Plos One. 13: e0204159. PMID 30226859 DOI: 10.1371/Journal.Pone.0204159 |
0.426 |
|
| 2018 |
Rodriguez FJ, Brosnan-Cashman JA, Allen SJ, Vizcaino MA, Giannini C, Camelo-Piragua S, Webb M, Matsushita M, Wadhwani N, Tabbarah A, Hamideh D, Jiang L, Chen L, Arvanitis LD, Alnajar HH, ... ... Heaphy CM, et al. Alternative lengthening of telomeres, ATRX loss and h3-k27m mutations in histologically defined pilocytic astrocytoma with anaplasia. Brain Pathology (Zurich, Switzerland). PMID 30192422 DOI: 10.1111/Bpa.12646 |
0.334 |
|
| 2018 |
Weber KA, Heaphy CM, Joshu CE, Lu J, Rohrmann S, Bienstock JL, Agurs-Collins T, Meeker AK, Platz EA. Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlations. Cancer Causes & Control : Ccc. PMID 29980985 DOI: 10.1007/S10552-018-1054-8 |
0.302 |
|
| 2018 |
Palsgrove DN, Brosnan-Cashman JA, Giannini C, Raghunathan A, Jentoft M, Bettegowda C, Gokden M, Lin D, Yuan M, Lin MT, Heaphy CM, Rodriguez FJ. Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 29973652 DOI: 10.1038/S41379-018-0103-X |
0.41 |
|
| 2018 |
Bell WR, Meeker AK, Rizzo A, Rajpara S, Rosenthal IM, Flores Bellver M, Aparicio Domingo S, Zhong X, Barber JR, Joshu CE, Canto-Soler MV, Eberhart CG, Heaphy CM. A UNIQUE TELOMERE DNA EXPANSION PHENOTYPE IN HUMAN RETINAL ROD PHOTORECEPTORS ASSOCIATED WITH AGING AND DISEASE. Brain Pathology (Zurich, Switzerland). PMID 29668072 DOI: 10.1111/Bpa.12618 |
0.351 |
|
| 2018 |
Brosnan-Cashman JA, Graham MK, Rizzo AJ, Myers K, Zhang R, Göger E, Zarinshenas R, Davis C, Yuan M, Rakheja D, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. Abstract B14: Establishment and characterization of in vitro models of alternative lengthening of telomeres (ALT) in pediatric high-grade glioma Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-B14 |
0.423 |
|
| 2018 |
Brosnan-Cashman JA, Heaphy CM, Meeker AK. Abstract 1467: Isolation and characterization of cancer cells containing ultrabright telomere DNA foci associated with alternative lengthening of telomeres (ALT): A novel utility for combined telomere-specific FISH and flow cytometry (Flow FISH) Cancer Research. 78: 1467-1467. DOI: 10.1158/1538-7445.Am2018-1467 |
0.482 |
|
| 2017 |
Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA. Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells. The Prostate. PMID 29164645 DOI: 10.1002/Pros.23462 |
0.396 |
|
| 2017 |
Baena-Del Valle JA, Zheng Q, Esopi DM, Rubenstein M, Hubbard GK, Moncaliano MC, Hruszkewycz A, Vaghasia A, Yegnasubramanian S, Wheelan SJ, Meeker AK, Heaphy CM, Graham MK, De Marzo AM. MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer. The Journal of Pathology. PMID 28888037 DOI: 10.1002/Path.4980 |
0.468 |
|
| 2017 |
VandenBussche CJ, Allison DB, Graham MK, Charu V, Lennon AM, Wolfgang CL, Hruban RH, Heaphy CM. Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors. Cancer. PMID 28371511 DOI: 10.1002/Cncy.21857 |
0.382 |
|
| 2017 |
Becker AP, Bell EH, Fleming J, McElroy JP, Fabian D, Beyer S, Salavaggione AL, Graham MK, Heaphy CM, Oehlke O, Staszewski O, Prinz M, Grosu A, Chakravarti A. Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas. Journal of Clinical Oncology. 35: 2064-2064. DOI: 10.1200/Jco.2017.35.15_Suppl.2064 |
0.352 |
|
| 2017 |
Barry W, Heaphy C, Meeker A. Abstract 3470: The promyelocytic leukemia (PML) protein modulates rate and localization of homologous recombination in human cell lines with the alternative lengthening of telomeres (ALT) pathway Cancer Research. 77: 3470-3470. DOI: 10.1158/1538-7445.Am2017-3470 |
0.398 |
|
| 2017 |
Brosnan-Cashman JA, Rizzo AJ, Goger E, Myers KM, Zarinshenas R, Davis C, Yuan M, Rakheja D, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. Abstract 3466: ALT-positive pediatric high grade glioma cells display chemosensitivity to ATR pathway inhibition Cancer Research. 77: 3466-3466. DOI: 10.1158/1538-7445.Am2017-3466 |
0.436 |
|
| 2017 |
Brosnan-Cashman JA, Yuan M, Rizzo AJ, Myers KM, Barry WT, Davis C, Esopi DM, Rakheja D, Raabe EH, Eberhart CG, Heaphy CM, Meeker AK. Abstract 3465: Context-dependent effects of ATRX loss on telomere biology in glioma cells Cancer Research. 77: 3465-3465. DOI: 10.1158/1538-7445.Am2017-3465 |
0.467 |
|
| 2017 |
Rizzo AJ, Brosnan-Cashman JA, Graham MK, Meeker AK, Heaphy CM. Abstract 3464: CRISPR-mediated inactivation of ATRX and DAXX in pancreatic neuroendocrine tumor cell lines Cancer Research. 77: 3464-3464. DOI: 10.1158/1538-7445.Am2017-3464 |
0.478 |
|
| 2016 |
Weber KA, Heaphy CM, Rohrmann S, Gonzalez B, Bienstock JL, Agurs-Collins T, Platz EA, Meeker AK. Influence of In Utero Maternal and Neonate Factors on Cord Blood Leukocyte Telomere Length: Clues to the Racial Disparity in Prostate Cancer? Prostate Cancer. 2016: 3691650. PMID 28070423 DOI: 10.1155/2016/3691650 |
0.353 |
|
| 2016 |
Holdhoff M, Guner G, Rodriguez FJ, Hicks JL, Zheng Q, Forman MS, Ye X, Grossman SA, Meeker AK, Heaphy CM, Eberhart CG, De Marzo AM, Arav-Boger R. Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry and in situ hybridization. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28034905 DOI: 10.1158/1078-0432.Ccr-16-1490 |
0.317 |
|
| 2016 |
Kim JY, Brosnan-Cashman JA, An S, Kim SJ, Song KB, Kim MS, Kim MJ, Hwang DW, Meeker AK, Yu E, Kim SC, Hruban RH, Heaphy CM, Hong SM. Alternative lengthening of telomeres in primary pancreatic neuroendocrine neoplasms is associated with aggressive clinical behavior and poor survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27663587 DOI: 10.1158/1078-0432.Ccr-16-1147 |
0.36 |
|
| 2016 |
Hackeng WM, Brosens LA, Poruk KE, Noë M, Hosoda W, Poling JS, Rizzo A, Campbell-Thompson M, Atkinson MA, Konukiewitz B, Klöppel G, Heaphy CM, Meeker AK, Wood LD. Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis. Human Pathology. PMID 27342911 DOI: 10.1016/J.Humpath.2016.06.006 |
0.347 |
|
| 2016 |
Shekhani MT, Barber JR, Bezerra SM, Heaphy CM, Roibon ND, Taheri D, Reis LO, Guner G, Joshu CE, Netto GJ, Meeker AK. Hi-res telomere FISH reveals intriguing anomalies in germ cell tumors. Human Pathology. PMID 27085557 DOI: 10.1016/J.Humpath.2016.03.015 |
0.422 |
|
| 2016 |
Suryo Rahmanto Y, Jung JG, Wu RC, Kobayashi Y, Heaphy CM, Meeker AK, Wang TL, Shih IM. Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells. The Journal of Biological Chemistry. PMID 26953344 DOI: 10.1074/Jbc.M115.707612 |
0.397 |
|
| 2016 |
Valle JABD, Zheng Q, Rubenstein M, Meeker AK, Heaphy CM, Hubbard G, Bieberich CJ, Yegnasubramanian S, Esopi D, Wheelan SJ, Marzo AMD. Abstract LB-160: Human telomerase RNA component (hTR/TERC) is consistently overexpressed in prostate cancer, required for cell proliferation and is positively regulated by MYC Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-160 |
0.491 |
|
| 2016 |
Graham MK, Brosnan-Cashman J, Rizzo A, Haffner M, Meeker A, Heaphy C. Abstract 4767: Generating and characterizing novel prostate cancer cell lines that employ the alternative lengthening of telomeres (ALT) telomere maintenance mechanism Cancer Research. 76: 4767-4767. DOI: 10.1158/1538-7445.Am2016-4767 |
0.512 |
|
| 2015 |
Bodelon C, Heaphy CM, Meeker AK, Geller B, Vacek PM, Weaver DL, Chicoine RE, Shepherd JA, Mahmoudzadeh AP, Patel DA, Brinton LA, Sherman ME, Gierach GL. Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsy. Bmc Cancer. 15: 823. PMID 26519084 DOI: 10.1186/S12885-015-1860-2 |
0.391 |
|
| 2015 |
Cochran RL, Cidado J, Kim M, Zabransky DJ, Croessmann S, Chu D, Wong HY, Beaver JA, Cravero K, Erlanger B, Parsons H, Heaphy CM, Meeker AK, Lauring J, Park BH. Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes. Oncotarget. PMID 26246475 DOI: 10.18632/Oncotarget.4595 |
0.383 |
|
| 2015 |
Cesare AJ, Heaphy CM, O'Sullivan RJ. Visualization of Telomere Integrity and Function In Vitro and In Vivo Using Immunofluorescence Techniques. Current Protocols in Cytometry / Editorial Board, J. Paul Robinson, Managing Editor ... [Et Al.]. 73: 12.40.1-12.40.31. PMID 26132175 DOI: 10.1002/0471142956.Cy1240S73 |
0.403 |
|
| 2015 |
Heaphy CM, Asch-Kendrick R, Argani P, Meeker AK, Cimino-Mathews A. Telomere length alterations unique to invasive lobular carcinoma. Human Pathology. 46: 1197-203. PMID 26092192 DOI: 10.1016/J.Humpath.2015.05.001 |
0.451 |
|
| 2015 |
Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Van Blarigan EL, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA. Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells. Cancer Prevention Research (Philadelphia, Pa.). 8: 737-42. PMID 25990087 DOI: 10.1158/1940-6207.Capr-15-0097 |
0.434 |
|
| 2015 |
Heaphy CM, Gaonkar G, Peskoe SB, Joshu CE, De Marzo AM, Lucia MS, Goodman PJ, Lippman SM, Thompson IM, Platz EA, Meeker AK. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. The Prostate. 75: 1160-6. PMID 25893825 DOI: 10.1002/Pros.22997 |
0.474 |
|
| 2015 |
Julin B, Shui I, Heaphy CM, Joshu CE, Meeker AK, Giovannucci E, De Vivo I, Platz EA. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer British Journal of Cancer. 112: 769-776. PMID 25562437 DOI: 10.1038/Bjc.2014.640 |
0.447 |
|
| 2015 |
Weber KA, Heaphy CM, Giovannucci E, Platz EA, Meeker AK. Abstract 832: Midlife racial differences In leukocyte telomere length and in associations between modifiable factors and telomere length Cancer Research. 75: 832-832. DOI: 10.1158/1538-7445.Am2015-832 |
0.355 |
|
| 2015 |
Shekhani MT, Barber J, Heaphy CM, Reis L, Guner G, Joshu C, Netto GJ, Meeker AK. Abstract 3783: High resolution telomere FISH analysis of testicular germ cell tumors reveals telomere anomalies specific to cancer subtypes and demonstrates telomere shortening as an early event in TGCT carcinogenesis Cancer Research. 75: 3783-3783. DOI: 10.1158/1538-7445.Am2015-3783 |
0.473 |
|
| 2014 |
Dogeas E, Karagkounis G, Heaphy CM, Hirose K, Pawlik TM, Wolfgang CL, Meeker A, Hruban RH, Cameron JL, Choti MA. Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases. Journal of the American College of Surgeons. 218: 628-35. PMID 24655849 DOI: 10.1016/J.Jamcollsurg.2014.01.001 |
0.366 |
|
| 2014 |
Hurwitz LM, Heaphy CM, Joshu CE, Isaacs WB, Konishi Y, De Marzo AM, Isaacs SD, Wiley KE, Platz EA, Meeker AK. Telomere length as a risk factor for hereditary prostate cancer. The Prostate. 74: 359-64. PMID 24285042 DOI: 10.1002/Pros.22755 |
0.457 |
|
| 2013 |
Haffner MC, Mosbruger T, Esopi DM, Fedor H, Heaphy CM, Walker DA, Adejola N, Gürel M, Hicks J, Meeker AK, Halushka MK, Simons JW, Isaacs WB, De Marzo AM, Nelson WG, et al. Tracking the clonal origin of lethal prostate cancer. The Journal of Clinical Investigation. 123: 4918-22. PMID 24135135 DOI: 10.1172/Jci70354 |
0.495 |
|
| 2013 |
Heaphy CM, Schreck KC, Raabe E, Mao XG, An P, Chu Q, Poh W, Jiao Y, Rodriguez FJ, Odia Y, Meeker AK, Eberhart CG. A glioblastoma neurosphere line with alternative lengthening of telomeres. Acta Neuropathologica. 126: 607-8. PMID 24022427 DOI: 10.1007/S00401-013-1174-X |
0.37 |
|
| 2013 |
Meeker A, Heaphy C. Gastroenteropancreatic endocrine tumors. Molecular and Cellular Endocrinology. 386: 101-20. PMID 23906538 DOI: 10.1016/J.Mce.2013.07.015 |
0.379 |
|
| 2013 |
Heaphy CM, Yoon GS, Peskoe SB, Joshu CE, Lee TK, Giovannucci E, Mucci LA, Kenfield SA, Stampfer MJ, Hicks JL, De Marzo AM, Platz EA, Meeker AK. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discovery. 3: 1130-41. PMID 23779129 DOI: 10.1158/2159-8290.Cd-13-0135 |
0.481 |
|
| 2013 |
Garcia-Rizo C, Fernandez-Egea E, Miller BJ, Oliveira C, Justicia A, Griffith JK, Heaphy CM, Bernardo M, Kirkpatrick B. Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression. Brain, Behavior, and Immunity. 28: 49-53. PMID 23207109 DOI: 10.1016/J.Bbi.2012.11.009 |
0.603 |
|
| 2013 |
Nguyen DN, Heaphy CM, de Wilde RF, Orr BA, Odia Y, Eberhart CG, Meeker AK, Rodriguez FJ. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathology (Zurich, Switzerland). 23: 237-43. PMID 22928601 DOI: 10.1111/J.1750-3639.2012.00630.X |
0.309 |
|
| 2013 |
Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Mucci LA, Giovanucci E, Stampfer MJ, Yoon GS, Lee T, Hicks JL, Marzo AMD, Meeker AK, Platz EA. Abstract PR06: Prediagnostic obesity and inactivity are associated with shorter telomere length in prostate cancer-associated stromal cells Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-Pr06 |
0.454 |
|
| 2013 |
Weber KA, Heaphy CM, Rohrmann S, Gonzalez B, Bienstock JL, Agurs-Collins T, Platz EA, Meeker AK. Abstract A63: Influence of in utero maternal and child factors on cord blood leukocyte telomere length and possible differences by race: Clues to the racial disparity in prostate cancer? Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-A63 |
0.389 |
|
| 2013 |
Heaphy CM, Haffner MC, Meeker AK. Abstract A06: A novel cell line model of the alternative lengthening of telomeres (ALT) telomere maintenance mechanism Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-A06 |
0.456 |
|
| 2012 |
Butler KS, Hines WC, Heaphy CM, Griffith JK. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas. Cancer Medicine. 1: 165-75. PMID 23342266 DOI: 10.1002/Cam4.14 |
0.773 |
|
| 2012 |
Jiao Y, Killela PJ, Reitman ZJ, Rasheed AB, Heaphy CM, de Wilde RF, Rodriguez FJ, Rosemberg S, Oba-Shinjo SM, Nagahashi Marie SK, Bettegowda C, Agrawal N, Lipp E, Pirozzi C, Lopez G, et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. 3: 709-22. PMID 22869205 DOI: 10.18632/Oncotarget.588 |
0.324 |
|
| 2012 |
de Wilde RF, Heaphy CM, Maitra A, Meeker AK, Edil BH, Wolfgang CL, Ellison TA, Schulick RD, Molenaar IQ, Valk GD, Vriens MR, Borel Rinkes IH, Offerhaus GJ, Hruban RH, Matsukuma KE. Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 25: 1033-9. PMID 22575867 DOI: 10.1038/Modpathol.2012.53 |
0.396 |
|
| 2011 |
Konishi H, Mohseni M, Tamaki A, Garay JP, Croessmann S, Karnan S, Ota A, Wong HY, Konishi Y, Karakas B, Tahir K, Abukhdeir AM, Gustin JP, Cidado J, Wang GM, ... ... Heaphy CM, et al. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 17773-8. PMID 21987798 DOI: 10.1073/Pnas.1110969108 |
0.44 |
|
| 2011 |
Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih IeM, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, et al. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. The American Journal of Pathology. 179: 1608-15. PMID 21888887 DOI: 10.1016/J.Ajpath.2011.06.018 |
0.537 |
|
| 2011 |
Wang Y, Meeker AK, Kowalski J, Tsai HL, Somervell H, Heaphy C, Sangenario LE, Prasad N, Westra WH, Zeiger MA, Umbricht CB. Telomere length is related to alternative splice patterns of telomerase in thyroid tumors. The American Journal of Pathology. 179: 1415-24. PMID 21763260 DOI: 10.1016/J.Ajpath.2011.05.056 |
0.395 |
|
| 2011 |
Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S, Offerhaus GJ, McLendon R, Rasheed BA, He Y, Yan H, et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science (New York, N.Y.). 333: 425. PMID 21719641 DOI: 10.1126/Science.1207313 |
0.401 |
|
| 2011 |
Heaphy CM, Meeker AK. The potential utility of telomere-related markers for cancer diagnosis. Journal of Cellular and Molecular Medicine. 15: 1227-38. PMID 21352473 DOI: 10.1111/J.1582-4934.2011.01284.X |
0.526 |
|
| 2011 |
Trujillo KA, Heaphy CM, Mai M, Vargas KM, Jones AC, Vo P, Butler KS, Joste NE, Bisoffi M, Griffith JK. Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. International Journal of Cancer. Journal International Du Cancer. 129: 1310-21. PMID 21105047 DOI: 10.1002/Ijc.25788 |
0.81 |
|
| 2011 |
Heaphy CM, Subhawong AP, Gross AL, Konishi Y, Kouprina N, Argani P, Visvanathan K, Meeker AK. Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 24: 194-200. PMID 21057458 DOI: 10.1038/Modpathol.2010.198 |
0.463 |
|
| 2011 |
Hong SM, Heaphy CM, Shi C, Eo SH, Cho H, Meeker AK, Eshleman JR, Hruban RH, Goggins M. Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias Modern Pathology. 24: 256-266. PMID 20871595 DOI: 10.1038/Modpathol.2010.181 |
0.306 |
|
| 2010 |
Heaphy CM, Fleet TM, Treat EG, Lee SJ, Smith AY, Davis MS, Griffith JK, Fischer EG, Bisoffi M. Organ-wide telomeric status in diseased and disease-free prostatic tissues. The Prostate. 70: 1471-9. PMID 20687220 DOI: 10.1002/Pros.21182 |
0.689 |
|
| 2010 |
Treat EG, Heaphy CM, Massie LW, Bisoffi M, Smith AY, Davis MS, Griffith JK. Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer. Urology. 75: 724-9. PMID 19615720 DOI: 10.1016/J.Urology.2009.04.032 |
0.688 |
|
| 2010 |
Heaphy CM, Haffner MC, Meeker AK. Abstract 3212: Development of a chemiluminescence-based single telomere length analysis (STELA) method Cancer Research. 70: 3212-3212. DOI: 10.1158/1538-7445.Am10-3212 |
0.438 |
|
| 2009 |
Subhawong AP, Heaphy CM, Argani P, Konishi Y, Kouprina N, Nassar H, Vang R, Meeker AK. The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 22: 1423-31. PMID 19734843 DOI: 10.1038/Modpathol.2009.125 |
0.494 |
|
| 2009 |
Heaphy CM, Griffith JK, Bisoffi M. Mammary field cancerization: molecular evidence and clinical importance. Breast Cancer Research and Treatment. 118: 229-39. PMID 19685287 DOI: 10.1007/S10549-009-0504-0 |
0.739 |
|
| 2009 |
Haaland CM, Heaphy CM, Butler KS, Fischer EG, Griffith JK, Bisoffi M. Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization. International Journal of Oncology. 35: 537-46. PMID 19639174 DOI: 10.3892/Ijo_00000365 |
0.79 |
|
| 2009 |
Fernandez-Egea E, Bernardo M, Heaphy CM, Griffith JK, Parellada E, Esmatjes E, Conget I, Nguyen L, George V, Stöppler H, Kirkpatrick B. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophrenia Bulletin. 35: 437-42. PMID 19279086 DOI: 10.1093/Schbul/Sbn169 |
0.595 |
|
| 2009 |
Heaphy CM, Bisoffi M, Joste NE, Baumgartner KB, Baumgartner RN, Griffith JK. Genomic instability demonstrates similarity between DCIS and invasive carcinomas. Breast Cancer Research and Treatment. 117: 17-24. PMID 18785004 DOI: 10.1007/S10549-008-0165-4 |
0.719 |
|
| 2008 |
Heaphy CM, Treat EG, Fleet TM, Bisoffi M, Smith AY, Davis MS, Fischer EG, Griffith JK. FIELD EFFECT REVEALED BY 3D-MAPPING OF TELOMERE DNA CONTENT AND ALLELIC IMBALANCE IN WHOLE MOUNT PROSTATES Journal of Urology. 179: 725-725. DOI: 10.1016/S0022-5347(08)62114-X |
0.672 |
|
| 2007 |
Heaphy CM, Bisoffi M, Griffith JK. Diagnostic significance of allelic imbalance in cancer. Expert Opinion On Medical Diagnostics. 1: 159-68. PMID 23489303 DOI: 10.1517/17530059.1.2.159 |
0.741 |
|
| 2007 |
Heaphy CM, Baumgartner KB, Bisoffi M, Baumgartner RN, Griffith JK. Telomere DNA content predicts breast cancer-free survival interval. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7037-43. PMID 18056180 DOI: 10.1158/1078-0432.Ccr-07-0432 |
0.74 |
|
| 2007 |
Heaphy CM, Hines WC, Butler KS, Haaland CM, Heywood G, Fischer EG, Bisoffi M, Griffith JK. Assessment of the frequency of allelic imbalance in human tissue using a multiplex polymerase chain reaction system. The Journal of Molecular Diagnostics : Jmd. 9: 266-71. PMID 17384220 DOI: 10.2353/Jmoldx.2007.060115 |
0.742 |
|
| 2007 |
Liu Z, Wan G, Heaphy C, Bisoffi M, Griffith JK, Hu CA. A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model. Molecular and Cellular Biochemistry. 297: 179-87. PMID 17119852 DOI: 10.1007/S11010-006-9345-X |
0.68 |
|
| 2007 |
Treat EG, Heaphy CM, Bisoffi M, Griffith JK, Smith AY, Davis MS. 1432: Telomere DNA Content Predicts Biochemical Recurrence in a Retrospective Analysis of Prostate Cancer Biopsies Journal of Urology. 177: 472-473. DOI: 10.1016/S0022-5347(18)31633-1 |
0.713 |
|
| 2006 |
Bisoffi M, Heaphy CM, Griffith JK. Telomeres: prognostic markers for solid tumors. International Journal of Cancer. 119: 2255-60. PMID 16858685 DOI: 10.1002/Ijc.22120 |
0.733 |
|
| 2006 |
Fordyce CA, Heaphy CM, Bisoffi M, Wyaco JL, Joste NE, Mangalik A, Baumgartner KB, Baumgartner RN, Hunt WC, Griffith JK. Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Research and Treatment. 99: 193-202. PMID 16752076 DOI: 10.1007/S10549-006-9204-1 |
0.797 |
|
| 2006 |
Candia BJ, Hines WC, Heaphy CM, Griffith JK, Orlando RA. Protease nexin-1 expression is altered in human breast cancer. Cancer Cell International. 6: 16. PMID 16737540 DOI: 10.1186/1475-2867-6-16 |
0.793 |
|
| 2006 |
Heaphy CM, Bisoffi M, Fordyce CA, Haaland CM, Hines WC, Joste NE, Griffith JK. Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. International Journal of Cancer. 119: 108-16. PMID 16450377 DOI: 10.1002/Ijc.21815 |
0.766 |
|
| 2005 |
Fordyce CA, Heaphy CM, Joste NE, Smith AY, Hunt WC, Griffith JK. Association between cancer-free survival and telomere DNA content in prostate tumors. The Journal of Urology. 173: 610-4. PMID 15643274 DOI: 10.1097/01.Ju.0000143195.49685.Ce |
0.807 |
|
| 2002 |
Fordyce CA, Heaphy CM, Griffith JK. Chemiluminescent measurement of telomere DNA content in biopsies. Biotechniques. 33: 144-6, 148. PMID 12139239 DOI: 10.2144/02331Md02 |
0.796 |
|
| Show low-probability matches. |